206 related articles for article (PubMed ID: 31054895)
1. Tissue-specific quantification and localization of androgen and estrogen receptors in prostate cancer.
Sehgal PD; Bauman TM; Nicholson TM; Vellky JE; Ricke EA; Tang W; Xu W; Huang W; Ricke WA
Hum Pathol; 2019 Jul; 89():99-108. PubMed ID: 31054895
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
3. Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer.
Vellky JE; Bauman TM; Ricke EA; Huang W; Ricke WA
Prostate; 2019 Dec; 79(16):1811-1822. PubMed ID: 31503366
[TBL] [Abstract][Full Text] [Related]
4. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.
Ricke EA; Williams K; Lee YF; Couto S; Wang Y; Hayward SW; Cunha GR; Ricke WA
Carcinogenesis; 2012 Jul; 33(7):1391-8. PubMed ID: 22535887
[TBL] [Abstract][Full Text] [Related]
5. [Implications of estrogens and their receptors for the development and progression of prostate cancer].
Bonkhoff H; Fixemer T
Pathologe; 2005 Nov; 26(6):461-8. PubMed ID: 16220300
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
Bonkhoff H
Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
[TBL] [Abstract][Full Text] [Related]
7. Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression.
Bauman TM; Vezina CM; Ricke EA; Halberg RB; Huang W; Peterson RE; Ricke WA
Hum Pathol; 2016 May; 51():124-33. PubMed ID: 27067790
[TBL] [Abstract][Full Text] [Related]
8. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs.
Pelletier G; Labrie C; Labrie F
J Endocrinol; 2000 May; 165(2):359-70. PubMed ID: 10810300
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F
Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue.
Brolin J; Skoog L; Ekman P
Prostate; 1992; 20(4):281-95. PubMed ID: 1376911
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.
Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z
Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer.
Bonkhoff H; Fixemer T; Hunsicker I; Remberger K
Prostate; 2000 Sep; 45(1):36-41. PubMed ID: 10960840
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a potential sign of prostate cancer metastasis.
Lévesque MH; El-Alfy M; Cusan L; Labrie F
Prostate; 2009 Nov; 69(15):1704-11. PubMed ID: 19670238
[TBL] [Abstract][Full Text] [Related]
15. [New insights into the role of estogens and their receptors in prostate cancer].
Bonkhoff H; Motherby H; Fixemer T
Urologe A; 2003 Dec; 42(12):1594-601. PubMed ID: 14668987
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
17. Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.
Hu DG; Selth LA; Tarulli GA; Meech R; Wijayakumara D; Chanawong A; Russell R; Caldas C; Robinson JL; Carroll JS; Tilley WD; Mackenzie PI; Hickey TE
Cancer Res; 2016 Oct; 76(19):5881-5893. PubMed ID: 27496708
[TBL] [Abstract][Full Text] [Related]
18. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece.
Solakidi S; Psarra AM; Nikolaropoulos S; Sekeris CE
Hum Reprod; 2005 Dec; 20(12):3481-7. PubMed ID: 16123086
[TBL] [Abstract][Full Text] [Related]
20. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]